$4.55
▼ $-0.14
(-2.99%)
Vol 348K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$138.6M
ROE
-374.1%
Margin
-466.1%
D/E
17.90
Beta
0.57
52W
$1–$3
Wall Street Consensus
18 analysts · Apr 20264
Strong Buy
13
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating
Price Chart
Similar Stocks
PBYI
Puma Biotechnology Inc
P/E 8.1
$299.8M
DMAC
DiaMedica Therapeutics Inc
$414.5M
CABA
Cabaletta Bio Inc
$210.8M
XOMA
Xoma Royalty Corp
P/E 15.2
$329.3M
XFOR
X4 Pharmaceuticals Inc
$349.7M
NGNE
Neurogene Inc
$319.1M
FBRX
Forte Biosciences Inc
$341.6M
SRZN
Surrozen Inc
$193.7M
GLSI
Greenwich Lifesciences Inc
$291.1M
PALI
Palisade Bio Inc
$350.2M
Earnings
Beat rate: 50.0%
Next Report
May 13, 2026
EPS Estimate: $-0.14
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.14 | — | — |
| Dec 2025 | $-0.12 | $-0.29 | $-0.17 |
| Sep 2025 | $-0.13 | $-0.25 | $-0.12 |
| Jun 2025 | $-0.21 | $-0.12 | +$0.09 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -230.2% | -188.5% | -230.2% | -230.2% | -374.1% | -374.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -257.5% | -429.4% | -377.9% | -377.9% | -466.1% | -466.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 5.72 | 0.00 | 5.72 | 5.72 | 17.90 | 17.90 |
| Current Ratio | 1.90 | 1.98 | 1.90 | 1.90 | 1.23 | 1.23 |
Key Ratios
ROA (TTM)
-170.7%
P/S (TTM)
9.47
P/B
1.5
EPS (TTM)
$-1.76
Rev Growth 3Y
+165.1%
52W High
$2.59
52W Low
$0.65
$0.65
52-Week Range
$2.59
How does IRD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IRD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
9.5
▼
26%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.5
▼
40%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IRD profitability vs Biotechnology peers
ROE
-374.1%
▼
456%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-466.1%
▼
63%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-170.7%
▼
265%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
IRD financial health vs Biotechnology peers
D/E ratio
17.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
1.2
▼
72%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.6
▼
41%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
IRD fundamentals radar
IRD
Peer median
Industry
IRD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IRD vs peers: key metrics
Latest News
Third Order Effects Begin: U.S. Airlines Hike Bag Fees As Jet Fuel …
ZeroHedge · Apr 05
Allbirds to sell assets to American Exchange Group for $39m
Yahoo Finance · Apr 01
A third inflationary shock in less than a decade is coming: who …
The Guardian · Apr 01
The Weird Obsession With Flying First-Class Among America's Anti-Capitalists
ZeroHedge · Mar 29
O'Reilly Exposes San Francisco As A Violent Third-World Drug Dystopia Infested By …
ZeroHedge · Mar 28